Target intelligence / Profile preview

ADP-ribosylation factor 3 (ARF3)

Target
ARF3
Molecular classification
Small GTPase, Ras superfamily, Guanine nucleotide-binding protein, Enzyme (regulatory)
01

Overview

ADP-ribosylation factor 3 (ARF3) is a member of the ARF family of small guanine nucleotide-binding proteins within the Ras superfamily. Like other ARF proteins, ARF3 functions as a molecular switch, cycling between GDP-bound (inactive) and GTP-bound (active) forms to regulate membrane dynamics. It is centrally involved in vesicle budding, cargo sorting, and membrane trafficking, especially within the Golgi apparatus, where it modulates the assembly of vesicle coat proteins (such as COP-I and adaptin complexes). ARF3, together with its homologs, coordinates critical aspects of protein trafficking, organelle structure, and signal transduction in eukaryotic cells[1][3][4][5][7][8]. While direct pharmacological targeting has not been established, its involvement in fundamental cellular logistics ties ARF3 to diverse diseases characterized by defective membrane trafficking, including certain cancers and congenital disorders[4][6].

Other names
ARF GTPase 3ARF3small GTP binding proteinADP ribosylation factor 3
02

Mechanism of action

Not applicable; no specific drugs target ARF3 in a clinical context as of the latest data

03

Biological functions

Vesicular traffickingCargo sortingVesicle buddingProtein trafficking between Golgi and endoplasmic reticulumActivation of phospholipase DRegulation of actin cytoskeletonMembrane delivery
04

Disease associations

Cancer (via trafficking and cell migration—extrapolated from ARF family roles)ScoliosisPectus excavatumOther (membrane trafficking dysregulation diseases)
05

Safety considerations

Targeting ARF3 could disrupt essential vesicular transport in healthy tissues, possibly leading to broad cellular dysfunction (inferred from function)

Beyond the preview

Go deeper on ADP-ribosylation factor 3 (ARF3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADP-ribosylation factor 3 (ARF3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call